Prunella vulgaris Extract Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating Androgen Levels, Cell Proliferation, and Apoptosis

Background/Objectives: Benign prostatic hyperplasia (BPH) is a prevalent urological condition affecting elderly men. Prunella vulgaris L. (PV), a perennial herbaceous plant native to Europe and Asia, has anti-inflammatory, antioxidant, and antimicrobial effects. In this study, we determined the effe...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceuticals (Basel, Switzerland) Vol. 17; no. 11; p. 1516
Main Authors: Kumbukgahadeniya, Poornima, Baek, Eun-Bok, Hong, Eun-Ju, Song, Jun-Yeop, Kwak, Youn-Gil, Jang, Mi-Ran, Ji, Hyo-Seong, Kwun, Hyo-Jung
Format: Journal Article
Language:English
Published: Basel MDPI AG 11-11-2024
MDPI
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background/Objectives: Benign prostatic hyperplasia (BPH) is a prevalent urological condition affecting elderly men. Prunella vulgaris L. (PV), a perennial herbaceous plant native to Europe and Asia, has anti-inflammatory, antioxidant, and antimicrobial effects. In this study, we determined the effect of PV extract on the development of BPH. Methods: Rats were treated via a daily hypodermic injection of testosterone propionate (TP; 3 mg/kg) for 4 weeks. Groups of BPH rats were treated with or without PV (60 or 80 mg/kg) by oral gavage. Results: In BPH model rats, PV considerably reduced their relative prostate weight and serum concentrations of dihydrotestosterone (DHT) and testosterone. The TP-induced increases in epithelial thickness in the prostate, proliferating cell nuclear antigen (PCNA) expression, and cyclin D1 expression were remarkably reduced, whereas terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL)-positive cells and cleaved caspase-3 levels were increased, in PV-treated rats compared to BPH rats. The mRNA expression levels of growth factors, such as transforming growth factor-β (TGF-β), fibroblast growth factor (FGF), and insulin-like growth factor (IGF-2), were significantly reduced in PV-treated rats. Mechanistically, the TP-induced activation of c-Jun N-terminal kinase (JNK) was reduced by PV administration. Conclusions: These results designate that PV effectively ameliorates the development of testosterone-induced BPH through anti-androgenic, anti-proliferative, and pro-apoptotic activities, suggesting that it could be a potential therapeutic substance for BPH.
AbstractList Background/Objectives: Benign prostatic hyperplasia (BPH) is a prevalent urological condition affecting elderly men. Prunella vulgaris L. (PV), a perennial herbaceous plant native to Europe and Asia, has anti-inflammatory, antioxidant, and antimicrobial effects. In this study, we determined the effect of PV extract on the development of BPH. Methods: Rats were treated via a daily hypodermic injection of testosterone propionate (TP; 3 mg/kg) for 4 weeks. Groups of BPH rats were treated with or without PV (60 or 80 mg/kg) by oral gavage. Results: In BPH model rats, PV considerably reduced their relative prostate weight and serum concentrations of dihydrotestosterone (DHT) and testosterone. The TP-induced increases in epithelial thickness in the prostate, proliferating cell nuclear antigen (PCNA) expression, and cyclin D1 expression were remarkably reduced, whereas terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL)-positive cells and cleaved caspase-3 levels were increased, in PV-treated rats compared to BPH rats. The mRNA expression levels of growth factors, such as transforming growth factor-β (TGF-β), fibroblast growth factor (FGF), and insulin-like growth factor (IGF-2), were significantly reduced in PV-treated rats. Mechanistically, the TP-induced activation of c-Jun N-terminal kinase (JNK) was reduced by PV administration. Conclusions: These results designate that PV effectively ameliorates the development of testosterone-induced BPH through anti-androgenic, anti-proliferative, and pro-apoptotic activities, suggesting that it could be a potential therapeutic substance for BPH.
Background/Objectives: Benign prostatic hyperplasia (BPH) is a prevalent urological condition affecting elderly men. Prunella vulgaris L. (PV), a perennial herbaceous plant native to Europe and Asia, has anti-inflammatory, antioxidant, and antimicrobial effects. In this study, we determined the effect of PV extract on the development of BPH. Methods: Rats were treated via a daily hypodermic injection of testosterone propionate (TP; 3 mg/kg) for 4 weeks. Groups of BPH rats were treated with or without PV (60 or 80 mg/kg) by oral gavage. Results: In BPH model rats, PV considerably reduced their relative prostate weight and serum concentrations of dihydrotestosterone (DHT) and testosterone. The TP-induced increases in epithelial thickness in the prostate, proliferating cell nuclear antigen (PCNA) expression, and cyclin D1 expression were remarkably reduced, whereas terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL)-positive cells and cleaved caspase-3 levels were increased, in PV-treated rats compared to BPH rats. The mRNA expression levels of growth factors, such as transforming growth factor-β (TGF-β), fibroblast growth factor (FGF), and insulin-like growth factor (IGF-2), were significantly reduced in PV-treated rats. Mechanistically, the TP-induced activation of c-Jun N-terminal kinase (JNK) was reduced by PV administration. Conclusions: These results designate that PV effectively ameliorates the development of testosterone-induced BPH through anti-androgenic, anti-proliferative, and pro-apoptotic activities, suggesting that it could be a potential therapeutic substance for BPH.
Author Ji, Hyo-Seong
Baek, Eun-Bok
Jang, Mi-Ran
Kumbukgahadeniya, Poornima
Song, Jun-Yeop
Hong, Eun-Ju
Kwak, Youn-Gil
Kwun, Hyo-Jung
AuthorAffiliation 2 Huons Foodience Co., Ltd., 19, Insam Gwangjang ro, Geumsan eup, Geumsan gun 32724, Republic of Korea; kyg@huonsfoodience.com (Y.-G.K.); rose86mr@huonsfoodience.com (M.-R.J.); hsji@huonsfoodience.com (H.-S.J.)
1 Department of Veterinary Pathology, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea; poornima.lakshini93@gmail.com (P.K.); baekeunbok@hanmail.net (E.-B.B.); bioeun59@naver.com (E.-J.H.); qldqld0610@gmail.com (J.-Y.S.)
AuthorAffiliation_xml – name: 1 Department of Veterinary Pathology, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea; poornima.lakshini93@gmail.com (P.K.); baekeunbok@hanmail.net (E.-B.B.); bioeun59@naver.com (E.-J.H.); qldqld0610@gmail.com (J.-Y.S.)
– name: 2 Huons Foodience Co., Ltd., 19, Insam Gwangjang ro, Geumsan eup, Geumsan gun 32724, Republic of Korea; kyg@huonsfoodience.com (Y.-G.K.); rose86mr@huonsfoodience.com (M.-R.J.); hsji@huonsfoodience.com (H.-S.J.)
Author_xml – sequence: 1
  givenname: Poornima
  orcidid: 0009-0009-2486-1562
  surname: Kumbukgahadeniya
  fullname: Kumbukgahadeniya, Poornima
– sequence: 2
  givenname: Eun-Bok
  orcidid: 0000-0001-7279-7774
  surname: Baek
  fullname: Baek, Eun-Bok
– sequence: 3
  givenname: Eun-Ju
  surname: Hong
  fullname: Hong, Eun-Ju
– sequence: 4
  givenname: Jun-Yeop
  orcidid: 0009-0009-8358-0664
  surname: Song
  fullname: Song, Jun-Yeop
– sequence: 5
  givenname: Youn-Gil
  surname: Kwak
  fullname: Kwak, Youn-Gil
– sequence: 6
  givenname: Mi-Ran
  surname: Jang
  fullname: Jang, Mi-Ran
– sequence: 7
  givenname: Hyo-Seong
  surname: Ji
  fullname: Ji, Hyo-Seong
– sequence: 8
  givenname: Hyo-Jung
  surname: Kwun
  fullname: Kwun, Hyo-Jung
BookMark eNpVkd1q3DAQhUVJIT_tTZ5AkLsSN56VbXmvwnZJm8BCQ0mvhX5GjoJWciV7yb5JHzcKCU0DghGcmfNJZ47JQYgBCTmF-itjy_pivAcOAC10H8gRNIum6hcNP_jvfkiOc36o65ZDA0fk722aA3ov6W72g0wu06vHKUk90dUWvYtJTpjpHeYp5glTwVU3wcwaDf2GwQ2B3qaiyMlper0fMY1eZiep2tNfOMy-CGGgq2BSHDDQDe7Q53O6LsznSe8sFoSL4ZzKYOhqjGMhufyJfLTSZ_z8Wk_I7-9Xd-vravPzx816tak0tG1XKQOKSWl026nOdhZUay1wpZGBbaCpbc96q4EtuAEu66Xq6x606RBASavYCbl88R1ntUWjMZTfezEmt5VpL6J04r0S3L0Y4k6UlJe8431xOHt1SPHPXIISD3FOoTxaMGDlAO956fry0qVLXDmh_YeAWjzvTrztjj0B9niTMQ
Cites_doi 10.1002/pros.2990150506
10.1089/rej.2017.1971
10.3390/antiox10071014
10.1002/pros.21030
10.1097/MOU.0b013e328316c357
10.1345/aph.1A228
10.3390/antiox13080952
10.2174/1381612825666190313121608
10.1007/s11934-019-0917-1
10.5534/wjmh.230122
10.1111/cpr.12415
10.1248/bpb.b17-00468
10.1016/S0022-5347(17)36966-5
10.1016/j.phymed.2023.155048
10.1023/A:1026057402945
10.1007/s00345-002-0248-5
10.1590/S1677-55382010000500006
10.1016/j.diff.2011.06.001
10.4081/aiua.2019.4.205
10.1002/j.1939-4640.1991.tb00272.x
10.3390/molecules29081843
10.1158/0008-5472.CAN-07-0418
10.1007/s11934-008-0048-6
10.1210/jcem.86.2.7211
10.1016/S0090-4295(01)01299-7
10.1046/j.1365-2265.1997.1100922.x
10.3390/biom14020243
10.1016/S0022-5347(17)49698-4
10.2147/OTT.S374908
10.1016/j.cyto.2011.06.024
10.2174/092986706779010315
10.3390/cancers13051158
10.2147/NDT.S1612
10.1002/(SICI)1097-4652(199610)169:1<97::AID-JCP10>3.0.CO;2-L
10.4103/0976-7800.98811
10.5534/wjmh.200012
10.3390/ijms24065904
10.1016/j.ucl.2009.07.003
10.1038/nrdp.2016.31
10.56434/j.arch.esp.urol.20237609.79
10.3390/ijms25094843
10.1080/13685538.2016.1272101
10.1124/jpet.119.260216
10.1038/s41419-020-2317-3
10.1007/s43188-021-00114-0
10.1590/S1677-5538.IBJU.2015.01.15
10.3389/fimmu.2023.1196434
10.5567/pharmacologia.2013.441.448
10.3389/fphar.2022.903171
10.1046/j.1464-410x.2000.00874.x
10.3892/etm.2012.524
ContentType Journal Article
Copyright 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2024 by the authors. 2024
Copyright_xml – notice: 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2024 by the authors. 2024
DBID AAYXX
CITATION
3V.
7XB
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
GNUQQ
GUQSH
M2O
MBDVC
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
5PM
DOI 10.3390/ph17111516
DatabaseName CrossRef
ProQuest Central (Corporate)
ProQuest Central (purchase pre-March 2016)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
ProQuest Central
ProQuest Central Student
Research Library Prep
Research Library (ProQuest Database)
Research Library (Corporate)
Publicly Available Content Database (Proquest) (PQ_SDU_P3)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest Research Library
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList
Publicly Available Content Database
CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1424-8247
ExternalDocumentID 10_3390_ph17111516
GeographicLocations Europe
GeographicLocations_xml – name: Europe
GrantInformation_xml – fundername: Ministry of Agriculture, Food, and Rural Affairs (MAFRA)
  grantid: 1220453
GroupedDBID ---
2WC
3V.
53G
5VS
8G5
AADQD
AAFWJ
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ADBBV
AEAQA
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
CCPQU
CITATION
DIK
DWQXO
EBD
ESX
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HH5
HYE
IAO
IHR
ITC
KQ8
M2O
MK0
MODMG
M~E
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
RIG
RPM
TUS
7XB
8FK
M48
MBDVC
PQEST
PQUKI
PRINS
Q9U
5PM
ID FETCH-LOGICAL-c1556-bd1b3aadc56b6f6f1b5ff17bce31f4140f838fc1327d17a09b8081cd6e11bafb3
IEDL.DBID RPM
ISSN 1424-8247
IngestDate Wed Nov 27 05:24:31 EST 2024
Wed Nov 27 13:44:30 EST 2024
Wed Nov 13 12:46:43 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1556-bd1b3aadc56b6f6f1b5ff17bce31f4140f838fc1327d17a09b8081cd6e11bafb3
ORCID 0009-0009-2486-1562
0009-0009-8358-0664
0000-0001-7279-7774
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11597678/
PQID 3133131787
PQPubID 2032350
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11597678
proquest_journals_3133131787
crossref_primary_10_3390_ph17111516
PublicationCentury 2000
PublicationDate 20241111
PublicationDateYYYYMMDD 2024-11-11
PublicationDate_xml – month: 11
  year: 2024
  text: 20241111
  day: 11
PublicationDecade 2020
PublicationPlace Basel
PublicationPlace_xml – name: Basel
PublicationTitle Pharmaceuticals (Basel, Switzerland)
PublicationYear 2024
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Traish (ref_31) 2020; 38
ref_50
Wang (ref_23) 2019; 25
Dvorkin (ref_56) 2002; 36
Wu (ref_55) 2012; 3
ref_54
Chen (ref_37) 2009; 69
Wijerathne (ref_51) 2017; 40
Busetto (ref_33) 2020; 91
Chatterjee (ref_6) 2003; 253
Chughtai (ref_1) 2016; 2
Lloyd (ref_7) 2019; 20
Khosravi (ref_43) 2001; 86
Wu (ref_47) 2011; 5
Blankstein (ref_15) 2016; 23
Barry (ref_3) 1992; 148
Lee (ref_30) 2024; 42
ref_25
ref_21
Asiedu (ref_29) 2017; 20
Fraile (ref_53) 2012; 2012
Zhang (ref_38) 2018; 21
Sukjamnong (ref_22) 2022; 38
ref_28
ref_27
ref_26
Correa (ref_42) 2015; 41
Isaacs (ref_9) 1989; 15
Lee (ref_49) 2022; 15
ref_35
ref_32
Facio (ref_18) 2010; 36
Quaresma (ref_16) 2019; 371
Caggia (ref_39) 2011; 56
Bartsch (ref_5) 2002; 19
Gong (ref_40) 2023; 120
Lambert (ref_11) 2008; 9
Gnanapragasam (ref_44) 2000; 86
Lawson (ref_10) 1997; 32
Kulig (ref_17) 2006; 13
Story (ref_46) 1996; 169
Sinowatz (ref_41) 2000; 15
Fan (ref_48) 2020; 11
Steers (ref_14) 2001; 58
Wong (ref_19) 2009; 19
Hegazi (ref_34) 2023; 76
Ney (ref_57) 2007; 3
Bushman (ref_4) 2009; 36
Rasool (ref_24) 2013; 4
McConnell (ref_8) 1991; 12
Laufer (ref_20) 2024; 163
Zhao (ref_52) 2018; 51
McLaren (ref_12) 2011; 82
Shrivastava (ref_13) 2012; 3
Ho (ref_45) 1997; 46
Berry (ref_2) 1984; 132
He (ref_36) 2007; 67
References_xml – volume: 15
  start-page: 33
  year: 1989
  ident: ref_9
  article-title: Etiology and disease process of benign prostatic hyperplasia
  publication-title: Prostate
  doi: 10.1002/pros.2990150506
  contributor:
    fullname: Isaacs
– volume: 21
  start-page: 313
  year: 2018
  ident: ref_38
  article-title: Prunella vulgaris L. Exerts a Protective Effect Against Extrinsic Aging Through NF-κB, MAPKs, AP-1, and TGF-β/Smad Signaling Pathways in UVB-Aged Normal Human Dermal Fibroblasts
  publication-title: Rejuvenation Res.
  doi: 10.1089/rej.2017.1971
  contributor:
    fullname: Zhang
– ident: ref_35
  doi: 10.3390/antiox10071014
– volume: 2012
  start-page: 169170
  year: 2012
  ident: ref_53
  article-title: MAP kinases and prostate cancer
  publication-title: J. Signal Transduct.
  contributor:
    fullname: Fraile
– volume: 69
  start-page: 1790
  year: 2009
  ident: ref_37
  article-title: Prostasin regulates iNOS and cyclin D1 expression by modulating protease-activated receptor-2 signaling in prostate epithelial cells
  publication-title: Prostate
  doi: 10.1002/pros.21030
  contributor:
    fullname: Chen
– volume: 19
  start-page: 7
  year: 2009
  ident: ref_19
  article-title: Phosphodiesterase 5 inhibitors in the management of benign prostatic hyperplasia and erectile dysfunction: The best of both worlds
  publication-title: Curr. Opin. Urol.
  doi: 10.1097/MOU.0b013e328316c357
  contributor:
    fullname: Wong
– volume: 36
  start-page: 1443
  year: 2002
  ident: ref_56
  article-title: Herbs for benign prostatic hyperplasia
  publication-title: Ann. Pharmacother.
  doi: 10.1345/aph.1A228
  contributor:
    fullname: Dvorkin
– ident: ref_26
  doi: 10.3390/antiox13080952
– volume: 25
  start-page: 359
  year: 2019
  ident: ref_23
  article-title: Prunella vulgaris: A comprehensive review of chemical constituents, pharmacological effects and clinical applications
  publication-title: Curr. Pharm. Des.
  doi: 10.2174/1381612825666190313121608
  contributor:
    fullname: Wang
– volume: 20
  start-page: 54
  year: 2019
  ident: ref_7
  article-title: Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation?
  publication-title: Curr. Urol. Rep.
  doi: 10.1007/s11934-019-0917-1
  contributor:
    fullname: Lloyd
– volume: 42
  start-page: 600
  year: 2024
  ident: ref_30
  article-title: The Role of Reactive Oxygen Species, Inflammation, and Endoplasmic Reticulum Stress Response in the Finasteride Protective Effect against Benign Prostate Hyperplasia
  publication-title: World J. Mens. Health
  doi: 10.5534/wjmh.230122
  contributor:
    fullname: Lee
– volume: 51
  start-page: e12415
  year: 2018
  ident: ref_52
  article-title: Finasteride accelerates prostate wound healing after thulium laser resection through DHT and AR signalling
  publication-title: Cell Prolif.
  doi: 10.1111/cpr.12415
  contributor:
    fullname: Zhao
– volume: 23
  start-page: 10
  year: 2016
  ident: ref_15
  article-title: BPH update: Medical versus interventional management
  publication-title: Can. J. Urol.
  contributor:
    fullname: Blankstein
– volume: 40
  start-page: 2125
  year: 2017
  ident: ref_51
  article-title: Quisqualis indica improves benign prostatic hyperplasia by regulating prostate cell proliferation and apoptosis
  publication-title: Biol. Pharm. Bull.
  doi: 10.1248/bpb.b17-00468
  contributor:
    fullname: Wijerathne
– volume: 5
  start-page: 4218
  year: 2011
  ident: ref_47
  article-title: Effects of sulfated polysaccharide extracted from Prunella vulgaris on endothelial cells
  publication-title: J. Med. Plants Res.
  contributor:
    fullname: Wu
– volume: 148
  start-page: 1549
  year: 1992
  ident: ref_3
  article-title: The American Urological Association symptom index for benign prostatic hyperplasia
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(17)36966-5
  contributor:
    fullname: Barry
– volume: 120
  start-page: 155048
  year: 2023
  ident: ref_40
  article-title: Bushen Tongluo formula ameliorated testosterone propionate-induced benign prostatic hyperplasia in rats
  publication-title: Phytomedicine
  doi: 10.1016/j.phymed.2023.155048
  contributor:
    fullname: Gong
– volume: 253
  start-page: 89
  year: 2003
  ident: ref_6
  article-title: The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer
  publication-title: Mol. Cell. Biochem.
  doi: 10.1023/A:1026057402945
  contributor:
    fullname: Chatterjee
– volume: 163
  start-page: 50
  year: 2024
  ident: ref_20
  article-title: Phytotherapy and Natural Agents in Symptomatic Benign Prostatic Hyperplasia (BPH)
  publication-title: Harefuah
  contributor:
    fullname: Laufer
– volume: 19
  start-page: 413
  year: 2002
  ident: ref_5
  article-title: Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia
  publication-title: World J. Urol.
  doi: 10.1007/s00345-002-0248-5
  contributor:
    fullname: Bartsch
– volume: 36
  start-page: 563
  year: 2010
  ident: ref_18
  article-title: Benign prostatic hyperplasia. Clinical treatment can complicate cataract surgery
  publication-title: Int. Braz. J. Urol.
  doi: 10.1590/S1677-55382010000500006
  contributor:
    fullname: Facio
– volume: 82
  start-page: 237
  year: 2011
  ident: ref_12
  article-title: Role of interleukins, IGF and stem cells in BPH
  publication-title: Differentiation
  doi: 10.1016/j.diff.2011.06.001
  contributor:
    fullname: McLaren
– volume: 91
  start-page: 205
  year: 2020
  ident: ref_33
  article-title: Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature
  publication-title: Arch. Ital. Urol. Androl.
  doi: 10.4081/aiua.2019.4.205
  contributor:
    fullname: Busetto
– volume: 12
  start-page: 356
  year: 1991
  ident: ref_8
  article-title: The pathophysiology of benign prostatic hyperplasia
  publication-title: J. Androl.
  doi: 10.1002/j.1939-4640.1991.tb00272.x
  contributor:
    fullname: McConnell
– ident: ref_28
  doi: 10.3390/molecules29081843
– volume: 67
  start-page: 8188
  year: 2007
  ident: ref_36
  article-title: Tissue-specific consequences of cyclin D1 overexpression in prostate cancer progression
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-0418
  contributor:
    fullname: He
– volume: 9
  start-page: 272
  year: 2008
  ident: ref_11
  article-title: Growth factors in benign prostatic hyperplasia: Basic science implications
  publication-title: Curr. Urol. Rep.
  doi: 10.1007/s11934-008-0048-6
  contributor:
    fullname: Lambert
– volume: 86
  start-page: 694
  year: 2001
  ident: ref_43
  article-title: Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jcem.86.2.7211
  contributor:
    fullname: Khosravi
– volume: 58
  start-page: 17
  year: 2001
  ident: ref_14
  article-title: 5α-reductase activity in the prostate
  publication-title: Urology
  doi: 10.1016/S0090-4295(01)01299-7
  contributor:
    fullname: Steers
– volume: 46
  start-page: 145
  year: 1997
  ident: ref_45
  article-title: Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia
  publication-title: Clin. Endocrinol.
  doi: 10.1046/j.1365-2265.1997.1100922.x
  contributor:
    fullname: Ho
– ident: ref_50
  doi: 10.3390/biom14020243
– volume: 132
  start-page: 474
  year: 1984
  ident: ref_2
  article-title: The development of human benign prostatic hyperplasia with age
  publication-title: J. Urol.
  doi: 10.1016/S0022-5347(17)49698-4
  contributor:
    fullname: Berry
– volume: 15
  start-page: 963
  year: 2022
  ident: ref_49
  article-title: Role of the JNK Pathway in Bladder Cancer
  publication-title: OncoTargets Ther.
  doi: 10.2147/OTT.S374908
  contributor:
    fullname: Lee
– volume: 56
  start-page: 403
  year: 2011
  ident: ref_39
  article-title: Modulation of YY1 and p53 expression by transforming growth factor-β3 in prostate cell lines
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2011.06.024
  contributor:
    fullname: Caggia
– volume: 13
  start-page: 3395
  year: 2006
  ident: ref_17
  article-title: Trends in the development of new drugs for treatment of benign prostatic hyperplasia
  publication-title: Curr. Med. Chem.
  doi: 10.2174/092986706779010315
  contributor:
    fullname: Kulig
– ident: ref_54
  doi: 10.3390/cancers13051158
– volume: 3
  start-page: 785
  year: 2007
  ident: ref_57
  article-title: Neurologic uses of botulinum neurotoxin type A
  publication-title: Neuropsychiatr. Dis. Treat.
  doi: 10.2147/NDT.S1612
  contributor:
    fullname: Ney
– volume: 32
  start-page: 22
  year: 1997
  ident: ref_10
  article-title: Role of growth factors in benign prostatic hyperplasia
  publication-title: Eur. Urol.
  contributor:
    fullname: Lawson
– volume: 169
  start-page: 97
  year: 1996
  ident: ref_46
  article-title: Expression of transforming growth factor beta 1 (TGF beta 1), -beta 2, and- beta 3 by cultured human prostate cells
  publication-title: J. Cell Physiol.
  doi: 10.1002/(SICI)1097-4652(199610)169:1<97::AID-JCP10>3.0.CO;2-L
  contributor:
    fullname: Story
– volume: 3
  start-page: 10
  year: 2012
  ident: ref_13
  article-title: Various treatment options for benign prostatic hyperplasia: A current update
  publication-title: J. Mid-Life Health
  doi: 10.4103/0976-7800.98811
  contributor:
    fullname: Shrivastava
– volume: 38
  start-page: 323
  year: 2020
  ident: ref_31
  article-title: Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’s Time to Sound the Alarm
  publication-title: World J. Mens. Health
  doi: 10.5534/wjmh.200012
  contributor:
    fullname: Traish
– ident: ref_32
  doi: 10.3390/ijms24065904
– volume: 15
  start-page: 475
  year: 2000
  ident: ref_41
  article-title: Cellular localization of fibroblast growth factor 2 (FGF-2) in benign prostatic hyperplasia
  publication-title: Histol. Histopathol.
  contributor:
    fullname: Sinowatz
– volume: 36
  start-page: 403
  year: 2009
  ident: ref_4
  article-title: Etiology, epidemiology, and natural history of benign prostatic hyperplasia
  publication-title: Urol. Clin. N. Am.
  doi: 10.1016/j.ucl.2009.07.003
  contributor:
    fullname: Bushman
– volume: 2
  start-page: 16031
  year: 2016
  ident: ref_1
  article-title: Benign prostatic hyperplasia
  publication-title: Nat. Rev. Dis. Primers
  doi: 10.1038/nrdp.2016.31
  contributor:
    fullname: Chughtai
– volume: 76
  start-page: 643
  year: 2023
  ident: ref_34
  article-title: Is Artificial Intelligence the Key to Revolutionizing Benign Prostatic Hyperplasia Diagnosis and Management
  publication-title: Arch. Esp. Urol.
  doi: 10.56434/j.arch.esp.urol.20237609.79
  contributor:
    fullname: Hegazi
– ident: ref_25
  doi: 10.3390/ijms25094843
– volume: 20
  start-page: 17
  year: 2017
  ident: ref_29
  article-title: The role of sex steroid hormones in benign prostatic hyperplasia
  publication-title: Aging Male
  doi: 10.1080/13685538.2016.1272101
  contributor:
    fullname: Asiedu
– volume: 371
  start-page: 106
  year: 2019
  ident: ref_16
  article-title: Revisiting the Pharmacodynamic Uroselectivity of α (1)-Adrenergic Receptor Antagonists
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.119.260216
  contributor:
    fullname: Quaresma
– volume: 11
  start-page: 126
  year: 2020
  ident: ref_48
  article-title: Bruceine D induces lung cancer cell apoptosis and autophagy via the ROS/MAPK signaling pathway in vitro and in vivo
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-020-2317-3
  contributor:
    fullname: Fan
– volume: 38
  start-page: 331
  year: 2022
  ident: ref_22
  article-title: Fimbristylis ovata and Artemisia vulgaris extracts inhibited AGE-mediated RAGE expression, ROS generation, and inflammation in THP-1 cells
  publication-title: Toxicol. Res.
  doi: 10.1007/s43188-021-00114-0
  contributor:
    fullname: Sukjamnong
– volume: 41
  start-page: 110
  year: 2015
  ident: ref_42
  article-title: Insulin-like growth factor (IGF)-I, IGF binding protein-3, and prostate cancer: Correlation with Gleason score
  publication-title: Int. Braz. J. Urol.
  doi: 10.1590/S1677-5538.IBJU.2015.01.15
  contributor:
    fullname: Correa
– ident: ref_27
  doi: 10.3389/fimmu.2023.1196434
– volume: 4
  start-page: 441
  year: 2013
  ident: ref_24
  article-title: Prunella vulgaris L.: A literature review on its therapeutic potentials
  publication-title: Pharmacologia
  doi: 10.5567/pharmacologia.2013.441.448
  contributor:
    fullname: Rasool
– ident: ref_21
  doi: 10.3389/fphar.2022.903171
– volume: 86
  start-page: 731
  year: 2000
  ident: ref_44
  article-title: Insulin-like growth factor II and androgen receptor expression in the prostate
  publication-title: BJU Int.
  doi: 10.1046/j.1464-410x.2000.00874.x
  contributor:
    fullname: Gnanapragasam
– volume: 3
  start-page: 919
  year: 2012
  ident: ref_55
  article-title: Prunella vulgaris aqueous extract attenuates IL-1β-induced apoptosis and NF-κB activation in INS-1 cells
  publication-title: Exp. Ther. Med.
  doi: 10.3892/etm.2012.524
  contributor:
    fullname: Wu
SSID ssj0057141
Score 2.3967612
Snippet Background/Objectives: Benign prostatic hyperplasia (BPH) is a prevalent urological condition affecting elderly men. Prunella vulgaris L. (PV), a perennial...
Background/Objectives: Benign prostatic hyperplasia (BPH) is a prevalent urological condition affecting elderly men. Prunella vulgaris L. (PV), a perennial...
SourceID pubmedcentral
proquest
crossref
SourceType Open Access Repository
Aggregation Database
StartPage 1516
SubjectTerms Androgens
Antioxidants
Apoptosis
Cancer therapies
Cell cycle
Cell growth
Enzymes
Hyperplasia
Insulin-like growth factors
Kinases
Prostate
Side effects
Testosterone
Tuberculosis
Title Prunella vulgaris Extract Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating Androgen Levels, Cell Proliferation, and Apoptosis
URI https://www.proquest.com/docview/3133131787
https://pubmed.ncbi.nlm.nih.gov/PMC11597678
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3BbtNAEF2RnrggSqkaWqqRinqKm27W3l2OIaTKAZAFqdSbtbvepZYSx4obRP6Ez2XGjklz5Wyt19bMet6T37xh7IMY2TghVaPk3EWxEjTIfYRkBaG1MAmG3NMf3dkP9e1Bf56STY7semEa0b6zxU25WN6UxWOjrayWbtjpxIbp1wmiGKyiSg97rIfgsOPo7fc3UTzmrRGpQEI_rB65wgOd0ETz56VnjycP1ZDPysvda_Zqhwth3O5_zF748g27Tltj6e0A5vs-qXoA15DuLae3J-xPut6QXsXArw31ZhQ1TH8_UQMUjJd-QW34CClhTmNkyBlhVfqIhnY4n8MnXxY_S0ip_YPsW2GG1HRdNe2VYLfwvZ1WjyUOSP24woyDLyQ1wueY4J60ckECmSbGAzBlDuNqVeFORf2W3d9N55NZtJu5EDlEFjKyObfCmNwl0sogA7dJCFxZ5wUPMbKxoIUODjmsyrkytx8tje5wufScWxOsOGVHJb7EGQMfh1v6S2t5rGKXeKu1iL3UmhtpkNX02VUXjqxqrTUypCQUtGwftD676CKV7Y5XnQlk1hyRj1Z9pg-i9-9OZJt9eAWzqbHP7rLn3f8vPWcvRwhuqCeR8wt29LTe-PesV-eby4bUXzYZ-Rfpkuz3
link.rule.ids 230,315,729,782,786,866,887,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwELXY5QAXvhGF_RgJtKdmW9eJbY7d0lUR3VUEReIWxY69G6lNo2aL6D_h5zKTNHR73bPl2NGzM_OUN28Y-yQGJoxI1Sg5t0GoBDVyHyBZwdRapBFC7uiP7uSHuv6lv4zJJke2tTC1aN-a_LyYL86L_LbWVpYL22t1Yr34aoRZDEZRpXsH7DFe2H6_ZenNFzhSPOSNFalASt8rb7nCKx1RT_P7wWeXUe7rIe8FmMvnD93aC_Zsm1LCsBl_yR654hU7ixtP6k0XZrsSq6oLZxDv3Ko3r9nfeLUmqUsKv9dU1pFXMP5zR7VTMFy4OVXwYzYKM-pAQ6YKy8IF1O_DugwuXJHfFBBT5Qg5v8IEWe2qrCszwWzge9PoHqMjkHByiYcVpqRSwn2McE2aOSdtTX08upAWGQzLZYkr5dUb9vNyPBtNgm27hsBiUiIDk3Ej0jSzkTTSS89N5D1XxjrBfYhEzmuhvUX6qzKu0v5nQ10_bCYd5yb1RrxlhwW-xDsGLvR9-sFreKhCGzmjtQid1JqnMkVC1GEfWxyTsnHlSJDNENrJDu0OO2ohTrY3s0oEknKOSZNWHab3YP__JHLc3h9BtGvn7Rbd9w-fesqeTGZX02T69frbB_Z0gDkSlTZyfsQO71Zrd8wOqmx9Uh_of0zwAdY
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nj9MwELXYRUJc-EYUFhgJtKdmU9dJbLiVbqsillUEReIW2Y7NRmrTqNki-k_4ucwkDd1e4ZwPO3p2Zp785g1jb8XQRDGpGhPObRBJQY3ch0hWMLUWOkbIHZ3ozr7Ky-_qfEI2Oe-7WphGtG9NcVYulmdlcdVoK6ulDTudWJh-HmMWg1FUqrDKfXjEbuOmHQw7pt7-hWPJI97akQqk9WF1xSVu65j6mt8MQPus8lATeSPITO__z_QesHu71BJG7T0P2S1XPmKnaetNve3DfF9qVffhFNK9a_X2MfudrjckedHwc0PlHUUNk1_XVEMFo6VbUCU_ZqUwp040ZK6wKl1AfT-sy-GDK4sfJaRUQUIOsDBDdruumgpNMFv40ja8xygJJKBc4aKFC1Ir4TzGOCY9uSCNTbNM-qDLHEbVqsKRivoJ-zadzMezYNe2IbCYnCSBybkRWuc2TkziE89N7D2XxjrBfYSEziuhvEUaLHMu9eCdoe4fNk8c50Z7I56y4xI_4hkDF_kBHfQaHsnIxs4oJSKXKMV1opEY9dibDsusat05MmQ1hHi2R7zHTjqYs90OrTOB5Jxj8qRkj6kD6P--iZy3D68g4o0Dd4fw839_9DW7k55Ps4uPl59esLtDTJWowpHzE3Z8vd64l-yozjevmjX9BzjHBFY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prunella+vulgaris+Extract+Ameliorates+Testosterone-Induced+Benign+Prostatic+Hyperplasia+by+Regulating+Androgen+Levels%2C+Cell+Proliferation%2C+and+Apoptosis&rft.jtitle=Pharmaceuticals+%28Basel%2C+Switzerland%29&rft.au=Kumbukgahadeniya%2C+Poornima&rft.au=Eun-Bok+Baek&rft.au=Eun-Ju%2C+Hong&rft.au=Jun-Yeop+Song&rft.date=2024-11-11&rft.pub=MDPI+AG&rft.eissn=1424-8247&rft.volume=17&rft.issue=11&rft.spage=1516&rft_id=info:doi/10.3390%2Fph17111516&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1424-8247&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1424-8247&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1424-8247&client=summon